missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human Glucosylceramidase/GBA Antibody, R&D Systems™

Mouse Monoclonal Antibody
Brand: R&D Systems MAB7410
This item is not returnable.
View return policy
Description
Glucosylceramidase/GBA Monoclonal specifically detects Glucosylceramidase/GBA in Human samples. It is validated for Western Blot, Simple Western, Immunocytochemistry.
Specifications
| Glucosylceramidase/GBA | |
| Monoclonal | |
| LYOPH | |
| Western Blot 1 ug/mL, Simple Western 10 ug/mL, Immunocytochemistry 8-25 ug/mL | |
| P04062 | |
| GBA | |
| Chinese hamster ovary cell line CHO-derived recombinant human Glucosylceramidase/GBA Met1-Gln536 Accession # P04062 | |
| 100 μg | |
| Primary | |
| Detects human Glucosylceramidase/GBA in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human Cytosolic beta-Glucosidase/GBA3 is observed. | |
| Human | |
| Purified |
| Western Blot, Immunocytochemistry | |
| 812201 | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| Acid beta-glucosidase, alglucerase, Beta-glucocerebrosidase, D-glucosyl-N-acylsphingosine glucohydrolase, EC 3.2.1.45, GBA, GBA1, GC, GCB, GLUC, glucosidase, beta, acid, glucosidase, beta; acid (includes glucosylceramidase), glucosylceramidase, imiglucerase, lysosomal glucocerebrosidase | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 2629 | |
| Sterile PBS to a final concentration of 0.5 mg/mL. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction